Antonio M. Serafin
Stellenbosch, WC, South Africa
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
BAG1, MGMT, FOXO1, and DNAJA1 as potential drug targets for radiosensitizing cancer cell lines.
Journal: International journal of radiation biology
Published: May 05, 2022
Selective therapeutic benefit of X-rays and inhibitors of EGFR, PI3K/mTOR, and Bcl-2 in breast, lung, and cervical cancer cells.
Journal: European journal of pharmacology
Published: May 31, 2021
The malignancy index is a robust predictor of prostate cancer.
Journal: Discovery medicine
Published: October 02, 2020
The malignancy index in plasma samples as a prostate cancer biomarker.
Journal: Discovery medicine
Published: June 16, 2018
Towards Establishing Capacity for Biological Dosimetry at Ghana Atomic Energy Commission.
Journal: Genome integrity
Published: February 21, 2017
Strong synergism between small molecule inhibitors of HER2, PI3K, mTOR and Bcl-2 in human breast cancer cells.
Journal: Toxicology in vitro : an international journal published in association with BIBRA
Published: March 30, 2016
Profiling adrenal 11β-hydroxyandrostenedione metabolites in prostate cancer cells, tissue and plasma: UPC2-MS/MS quantification of 11β-hydroxytestosterone, 11keto-testosterone and 11keto-dihydrotestosterone.
Journal: The Journal of steroid biochemistry and molecular biology
Published: February 01, 2016
Flow cytometry-assisted quantification of γH2AX expression has potential as a rapid high-throughput biodosimetry tool.
Journal: Radiation and environmental biophysics
Published: November 16, 2015
Influence of freeze-drying on the recovery of the tumour invasion markers uPA and PAI-1 from prostate cancer resections.
Journal: Annals of clinical biochemistry
Published: October 21, 2014
Further evaluation of uPA and PAI-1 as biomarkers for prostatic diseases.
Journal: Journal of cancer research and clinical oncology
Published: October 01, 2014
In vitro radiosensitization by pentoxifylline does not depend on p53 status.
Journal: International journal of radiation biology
Published: February 01, 2013
uPA/PAI-1 ratios distinguish benign prostatic hyperplasia and prostate cancer.
Journal: Journal of cancer research and clinical oncology
Published: December 10, 2012
Last Updated: 09/26/2026